These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 4148660)
1. Specific indications for different classes of phenothiazines. Hollister LE; Overall JE; Kimbell I; Pokorny A Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660 [No Abstract] [Full Text] [Related]
2. Prediction of improvement in schizophrenia under four phenothiazines. Goldberg SC; Mattsson N; Cole JO; Klerman GL Arch Gen Psychiatry; 1967 Jan; 16(1):107-17. PubMed ID: 6066689 [No Abstract] [Full Text] [Related]
3. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow. Hollister LE Adv Biochem Psychopharmacol; 1974; 9(0):667-73. PubMed ID: 4151921 [No Abstract] [Full Text] [Related]
4. Schizophrenic subtypes defined by response to drugs and placebo. Goldberg SC; Mattsson NB Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985 [No Abstract] [Full Text] [Related]
5. Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review. Otręba M; Kośmider L; Rzepecka-Stojko A Eur J Pharmacol; 2020 Nov; 887():173553. PubMed ID: 32949606 [TBL] [Abstract][Full Text] [Related]
6. Piperacetazine in ambulatory chronic schizophrenic patients. Rada RT; Donlon PT Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665 [No Abstract] [Full Text] [Related]
7. Drug treatment in newly admitted schizophrenic patients. Clark ML; Huber WK; Charalampous KD; Serafetinides EA; Trousdale W; Colmore JP Arch Gen Psychiatry; 1971 Nov; 25(5):404-9. PubMed ID: 4943915 [No Abstract] [Full Text] [Related]
8. Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines. Schooler NR; Boothe H; Goldberg SC Arch Gen Psychiatry; 1971 Aug; 25(2):138-47. PubMed ID: 5106102 [No Abstract] [Full Text] [Related]
9. Performance tests in a study of phenothiazines in schizophrenia: caveats and conclusions. Schooler NR; Goldberg SC Psychopharmacologia; 1972; 24(1):81-98. PubMed ID: 5062969 [No Abstract] [Full Text] [Related]
10. Maintenance antipsychotic drugs do prevent relapse: a reply to Tobias and MacDonald. Davis JM; Gosenfeld L; Tsai CC Psychol Bull; 1976 May; 83(3):431-47. PubMed ID: 6986 [No Abstract] [Full Text] [Related]
11. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics. Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133 [TBL] [Abstract][Full Text] [Related]
12. The comparative effectiveness of eight phenothiazines. Hanlon TE; Michaux MH; Ota KY; Shaffer JW; Kurland AA Psychopharmacologia; 1965 Feb; 7(2):89-106. PubMed ID: 5318926 [No Abstract] [Full Text] [Related]
13. Low serum neuroleptic levels predict relapse in schizophrenic patients. Brown WA; Laughren T; Chisholm E; Williams BW Arch Gen Psychiatry; 1982 Sep; 39(9):998-1000. PubMed ID: 6126172 [TBL] [Abstract][Full Text] [Related]
14. Work performance versus clinical assessment in the evaluation of phenothiazine therapy. Harper P; Chacon C Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):50-5. PubMed ID: 9959 [No Abstract] [Full Text] [Related]
15. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia]. Termińska K; Mrowiec W Psychiatr Pol; 1989; 23(1):24-30. PubMed ID: 2573098 [TBL] [Abstract][Full Text] [Related]
16. Changes in primary process expression in hospitalized schizophrenics treated with phenothiazines: two projective tasks compared. Ebert JN; Ewing JH; Rogers MH; Reynolds DJ J Genet Psychol; 1977 Mar; 130(1st Half):83-94. PubMed ID: 16082 [TBL] [Abstract][Full Text] [Related]
17. A word association measure of severity of current symptoms in schizophrenia. De Wolfe AS J Clin Psychol; 1973 Jan; 29(1):11-4. PubMed ID: 4405163 [No Abstract] [Full Text] [Related]